E
Elif Sagsak
Researcher at University of Health Sciences Antigua
Publications - 24
Citations - 222
Elif Sagsak is an academic researcher from University of Health Sciences Antigua. The author has contributed to research in topics: Medicine & Calcitriol. The author has an hindex of 8, co-authored 20 publications receiving 153 citations. Previous affiliations of Elif Sagsak include Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Subclinical left ventricular systolic and diastolic dysfunction in type 1 diabetic children and adolescents with good metabolic control.
Tamer Yoldaş,Utku Arman Örün,Elif Sagsak,Zehra Aycan,Özkan Kaya,Senem Özgür,Selmin Karademir +6 more
TL;DR: This study was designed to assess whether type 1 diabetic children and adolescents with good metabolic control have early echocardiographic signs of subclinical left ventricular dysfunction and whether diabetes duration has any influence, using conventional and nonconventional echOCardiographic tools.
Journal ArticleDOI
Treatment experience and long-term follow-up data in two severe neonatal hyperparathyroidism cases.
Senay Savas-Erdeve,Elif Sagsak,Meliksah Keskin,Corinne Magdelaine,Anne Lienhardt-Roussie,Erdal Kurnaz,Semra Çetinkaya,Zehra Aycan +7 more
TL;DR: The neurological development is consistent with age in both cases while case 2 has mild mental retardation and normocalcemia is ensured with calcitriol in both case.
Journal ArticleDOI
An uncommon cause of hypoglycemia: insulin autoimmune syndrome.
Senay Savas-Erdeve,Sebahat Yılmaz Ağladıoğlu,Aşan Önder,Havva Nur Peltek Kendirci,Veysel Nijat Baş,Elif Sagsak,Semra Çetinkaya,Zehra Aycan +7 more
TL;DR: In all hyperinsulinemic hypoglycemia cases, IAS should be considered in the differential diagnosis and insulin antibody measurements should be carried out.
Journal ArticleDOI
Urinary C-Peptide/Creatinine Ratio Can Distinguish Maturity-Onset Diabetes of the Young from Type 1 Diabetes in Children and Adolescents: A Single-Center Experience.
TL;DR: It is shown that the UCPCR and fasting C-peptide levels in children and adolescents can distinguish patients with MODY from patients with T1DM with high specificity and sensitivity.
Journal ArticleDOI
Risk factors affecting the development of nephrocalcinosis, the most common complication of hypophosphatemic rickets.
TL;DR: The increased phosphate dose administered for treatment to play a role in nephrocalcinosis development is found, and the mean dose of calcitriol and phosphate was detected to be high with a statistically significant difference.